Home NDC 61755-014 VEOPOZ
Product NDC 61755-014
11-digit product format 617550014
Labeler code 61755
Product ID 61755-014_a8be5cf0-49ba-4795-a2e5-7ea07f495958
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Pozelimab
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS; SUBCUTANEOUS
Labeler Regeneron Pharmaceuticals, Inc.
Application BLA761339
Marketing category BLA
Marketing start 2023-08-18
Substance POZELIMAB
Active strength 200 mg/mL
Pharmacologic classes Complement Inhibitor [EPC], Complement Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base VEOPOZ
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength POZELIMAB 200 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 0JJ21K6L2I Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2663945 Internal RxNorm lookup 2663952 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61755-014-00 VEOPOZ 2 mL in 1 VIAL, SINGLE-DOSE INJECTION, SOLUTION 2 6 61755-014-01 VEOPOZ 1 in 1 CARTON INJECTION, SOLUTION 1 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61755-014 VEOPOZ (POZELIMAB) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.] 5 Current NDC, 2 package rows 20240322_a8d6f10e-9430-450a-a3dd-b538f9b2a308.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join VEOPOZ POZELIMAB Regeneron Pharmaceuticals, Inc. a8d6f10e-9430-450a-a3dd-b538f9b2a308 2025-12-04 Boxed warning, Warnings, Adverse reactions Exact identifier application number: BLA761339 ndc (product): 61755-014
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761339 Veopoz pozelimab-bbfg 351(a) Rx 2026-06-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 61755-014-00 61755001400 2 mL in 1 VIAL, SINGLE-DOSE 2 ml Historical 61755-014-01 61755001401 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01) / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00) 2023-08-18 No No Current